• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com

Home » News » Business

Feb 28, 2013, 09.36 AM | Source: PTI

Jubilant Life gets warning letter from USFDA

Drug firm Jubilant Life Sciences today said US health regulator has issued a warning letter for violation of manufacturing norms at its facility in Canada.

Like this story, share it with millions of investors on M3

Jubilant Life gets warning letter from USFDA

Drug firm Jubilant Life Sciences today said US health regulator has issued a warning letter for violation of manufacturing norms at its facility in Canada.

Post Your Comments

Share Cancel

Drug firm Jubilant Life Sciences today said US health regulator has issued a warning letter for violation of manufacturing norms at its facility in Canada.

"Jubilant HollisterStier General Partnership (JHS) located at Kirkland, Quebec, Canada has been issued a warning letter (WL) by US Food and Drug Administration (FDA) identifying significant violations of current good
manufacturing practices (cGMP) regulations,"  Jubilant Life Sciences said in a filing to the BSE.

As required by FDA, JHS will respond to this letter by March 15, 2013, it added.

"The response will provide details as to what corrective action has already been completed, as well as, additional detail as to how the facility will prevent the re occurrence of the items found to be objectionable to the FDA," Jubilant Life Sciences said.

Also read: Pharma sector expects sweet pill in upcoming Budget

USFDA had specified in its letter that until all corrections have been completed, it may withhold approval of new applications or supplements listing JHS as the drug product manufacturer.

"We expect that the on-going manufacturing, distribution and sale of products will not be affected by this warning letter. JHS is committed to implementing the necessary corrective actions required to address the FDA concerns, and
will work closely with the FDA to bring resolution to this matter," it added.

Shares of Jubilant Life Sciences today closed at Rs 176.45 per scrip on BSE, down sharp 4.90 percent from its previous close.

Jubilant Life stock price

On February 09, 2016, Jubilant Life Sciences closed at Rs 355.25, down Rs 10.4, or 2.84 percent. The 52-week high of the share was Rs 455.00 and the 52-week low was Rs 138.00.


The latest book value of the company is Rs 122.11 per share. At current value, the price-to-book value of the company was 2.91.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Jubilant Life gets warning letter from USFDA

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login